AURA logo

AURA
Aura Biosciences Inc

245
Mkt Cap
$436.22M
Volume
224,165.00
52W High
$7.48
52W Low
$4.35
PE Ratio
-3.75
AURA Fundamentals
Price
$6.80
Prev Close
$6.78
Open
$6.81
50D MA
$6.03
Beta
1.37
Avg. Volume
291,960.73
EPS (Annual)
-$1.76
P/B
3.16
Rev/Employee
$0.00
$201.98
Loading...
Loading...
News
all
press releases
Aura Biosciences, Inc. (AURA) Just Flashed Golden Cross Signal: Do You Buy?
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
Zacks·1d ago
News Placeholder
More News
News Placeholder
HC Wainwright Lifts Earnings Estimates for Aura Biosciences
Aura Biosciences, Inc. (NASDAQ:AURA - Free Report) - Equities researchers at HC Wainwright increased their Q1 2026 earnings estimates for Aura Biosciences in a research report issued on Monday, March...
MarketBeat·4d ago
News Placeholder
Is Aura Biosciences (AURA) Stock Outpacing Its Medical Peers This Year?
Here is how Aura Biosciences, Inc. (AURA) and Biodesix, Inc. (BDSX) have performed compared to their sector so far this year.
Zacks·5d ago
News Placeholder
Aura Biosciences (NASDAQ:AURA) Upgraded by Wall Street Zen to "Hold" Rating
Wall Street Zen raised Aura Biosciences from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat·8d ago
News Placeholder
Wall Street Analysts Predict a 201.49% Upside in Aura Biosciences (AURA): Here's What You Should Know
The mean of analysts' price targets for Aura Biosciences (AURA) points to a 201.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks·9d ago
News Placeholder
FY2030 Earnings Forecast for AURA Issued By HC Wainwright
Aura Biosciences, Inc. (NASDAQ:AURA - Free Report) - HC Wainwright issued their FY2030 earnings estimates for shares of Aura Biosciences in a report issued on Monday, March 30th. HC Wainwright analyst A. Maldonado forecasts that the company will earn ($0.35) per share for the year. HC Wainwright cur...
MarketBeat·9d ago
News Placeholder
Aura Biosciences (NASDAQ:AURA) Earns Buy Rating from HC Wainwright
HC Wainwright restated a "buy" rating and set a $22.00 price objective on shares of Aura Biosciences in a research report on Monday...
MarketBeat·12d ago
News Placeholder
Aura Biosciences, Inc. (NASDAQ:AURA) Given Average Rating of "Hold" by Brokerages
Shares of Aura Biosciences, Inc. (NASDAQ:AURA - Get Free Report) have been assigned an average rating of "Hold" from the five brokerages that are covering the stock, Marketbeat Ratings reports. One...
MarketBeat·16d ago
News Placeholder
Is Aura Biosciences (AURA) Outperforming Other Medical Stocks This Year?
Here is how Aura Biosciences, Inc. (AURA) and Elicio Therapeutics (ELTX) have performed compared to their sector so far this year.
Zacks·22d ago
News Placeholder
Aura Biosciences (AURA) to Release Earnings on Monday
Aura Biosciences (NASDAQ:AURA) will be releasing its Q4 2025 earnings before the market opens on Monday, March 23. (View Earnings Report at...
MarketBeat·26d ago
<
1
2
...
>

Latest AURA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.